Canada markets closed

Neurocrine Biosciences, Inc. (NBIX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
140.71+0.88 (+0.63%)
At close: 04:00PM EDT
142.26 +1.55 (+1.10%)
After hours: 07:55PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 14.06B
Enterprise Value 13.36B
Trailing P/E 37.97
Forward P/E 27.10
PEG Ratio (5 yr expected) 0.46
Price/Sales (ttm)7.24
Price/Book (mrq)5.89
Enterprise Value/Revenue 6.74
Enterprise Value/EBITDA 26.89

Trading Information

Stock Price History

Beta (5Y Monthly) 0.28
52-Week Change 342.83%
S&P500 52-Week Change 322.38%
52 Week High 3148.37
52 Week Low 389.04
50-Day Moving Average 3137.15
200-Day Moving Average 3122.26

Share Statistics

Avg Vol (3 month) 3908.06k
Avg Vol (10 day) 3925.3k
Shares Outstanding 5100.64M
Implied Shares Outstanding 6100.64M
Float 899.41M
% Held by Insiders 11.00%
% Held by Institutions 194.64%
Shares Short (Apr 15, 2024) 42.02M
Short Ratio (Apr 15, 2024) 42.26
Short % of Float (Apr 15, 2024) 42.35%
Short % of Shares Outstanding (Apr 15, 2024) 42.01%
Shares Short (prior month Mar 15, 2024) 42.48M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Dec 29, 1995
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 18.65%
Operating Margin (ttm)20.43%

Management Effectiveness

Return on Assets (ttm)10.08%
Return on Equity (ttm)18.16%

Income Statement

Revenue (ttm)1.98B
Revenue Per Share (ttm)20.15
Quarterly Revenue Growth (yoy)22.60%
Gross Profit (ttm)N/A
EBITDA 492.9M
Net Income Avi to Common (ttm)369.7M
Diluted EPS (ttm)3.69
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.21B
Total Cash Per Share (mrq)12.03
Total Debt (mrq)410.7M
Total Debt/Equity (mrq)17.21%
Current Ratio (mrq)2.52
Book Value Per Share (mrq)23.72

Cash Flow Statement

Operating Cash Flow (ttm)645.4M
Levered Free Cash Flow (ttm)719.32M